FUSN

Fusion Pharmaceuticals Inc. Common Shares
FUSN

Overview Fund Activity
Delisted

FUSN was delisted on the 3rd of June, 2024.

Back to rankings

77 hedge funds and large institutions have $586M invested in Fusion Pharmaceuticals Inc. Common Shares in 2023 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
77
Holders Change
+37
Holders Change %
+92.5%
% of All Funds
1.13%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
40
Increased
17
Reduced
8
Closed
3
Calls
$592K
Puts
$172K
Net Calls
+$420K
Net Calls Change
+$420K

Top Buyers

1
DM
Deerfield Management
New York
$61.5M
2
Fidelity Investments
Fidelity Investments
Massachusetts
$51.1M
3
William Blair & Company
William Blair & Company
Illinois
$9.55M
4
Wellington Management Group
Wellington Management Group
Massachusetts
$7.15M
5
APM
Avidity Partners Management
Texas
$62.5M

Top Sellers

1
AG
Artal Group
Luxembourg
$9.66M
2
SFM
Sphera Funds Management
Israel
$10.4M
3
GTC
Ghost Tree Capital
New York
$0
4
UOC
UBS O'Connor
Illinois
$2.05M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
$2.82M
Name Holding Trade Value Shares
Change 		Shares
Change %
TWC
76
TD Waterhouse Canada
Ontario, Canada
$5.92K – – –
Osaic Holdings
77
Osaic Holdings
Arizona
$826 +$826 +86 New
GTC
78
Ghost Tree Capital
New York
– -$633K -243,287 Closed
DWA
79
Dorsey Wright & Associates
California
– -$2.28K -878 Closed
National Bank of Canada
80
National Bank of Canada
Quebec, Canada
– -$1.19K -500 Closed
1 2 3
4